Health ❯ Patient Care

Treatment Options

Medication Innovative Therapies Clinical Trials Medication Adherence Medications Oral Medications Symptom Management Expanded Access Programs Complications Gene Therapy

CDC Flags Rapid Rise of Extensively Drug-Resistant Shigella in U.S.

The agency warns the strain is spreading within the country, leaving no approved oral treatments.

Miss North Carolina 2024 Carrie Everett Dies at 22 After Rare Gastric Cancer

FDA Approves Awiqli, First Once-Weekly Basal Insulin for Type 2 Diabetes

Heart Risks Rebound After GLP-1 Breaks, New Data Show Continuous Use Is Safest

Repurposed Epilepsy Drug Cuts Sleep Apnea Events by Up to 47% in Phase II Trial

Early-Onset Colorectal Cancer Surges, Prompting Fresh Calls for Screening at 45

Ahead of World Glaucoma Day, Experts Urge Annual Eye Exams and Reject Cannabis as Treatment

Polilaminina Enters Regulated Testing as Lead Researcher Moves to Correct Preprint

Compass Pathways’ Psilocybin Therapy Hits Phase 3 Goal in Treatment-Resistant Depression

Eli Lilly to Acquire Orna Therapeutics in Up to $2.4 Billion Bet on In Vivo CAR‑T

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

Emma Willis Reveals Lifelong Heart Defect as She Backs BHF Awareness Drive

Study Ties NT‑proBNP Blood Test to Complication Risk in Hypertrophic Cardiomyopathy

Tohoku University Team to Launch Investigator-Led Trial of New Mitochondrial Disease Drug in December

Johnson & Johnson to Buy Halda Therapeutics for $3.05 Billion to Bolster Oncology Pipeline

CHMP Backs Brinsupri as First EU Therapy for Non‑Cystic Fibrosis Bronchiectasis

Study Finds Higher Parkinson's Risk Among People With Restless Leg Syndrome

Cannabis Extract VER-01 Eases Chronic Low Back Pain in Phase 3 Trial

Gene Therapy Slows Huntington’s Progression by 75% in Three-Year Trial

EU Panel Backs Tezspire for Chronic Rhinosinusitis With Nasal Polyps